X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6) 6
oncology (6) 6
breast cancer (4) 4
cancer (4) 4
female (4) 4
index medicus (4) 4
chemotherapy (3) 3
middle aged (3) 3
mutation (3) 3
survival (3) 3
tumors (3) 3
adult (2) 2
analysis (2) 2
animals (2) 2
dextran (2) 2
dna (2) 2
gene expression (2) 2
liver metastases (2) 2
medical prognosis (2) 2
medicine & public health (2) 2
metastasis (2) 2
oncology, experimental (2) 2
ovarian neoplasms - genetics (2) 2
ovarian neoplasms - pathology (2) 2
pancreatic cancer (2) 2
prognosis (2) 2
research (2) 2
research article (2) 2
18f-misonidazole-pet (1) 1
18f‐misonidazole‐pet (1) 1
1st-line treatment (1) 1
6q24-26 deletion (1) 1
6q24.2-26 deletion (1) 1
6q24.2–26 deletion (1) 1
aberrations (1) 1
age (1) 1
aged (1) 1
aged, 80 and over (1) 1
american joint committee (1) 1
angiogenesis (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
anthracycline (1) 1
anti-egfr (1) 1
antiangiogenics (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
article (1) 1
articles (1) 1
benzimidazoles - therapeutic use (1) 1
bevacizumab (1) 1
biomarker (1) 1
biomarkers (1) 1
biomarkers, tumor - biosynthesis (1) 1
biomarkers, tumor - genetics (1) 1
biometry (1) 1
brca1 (1) 1
brca1/2 mutation (1) 1
breast - blood supply (1) 1
breast - diagnostic imaging (1) 1
breast density (1) 1
breast neoplasms - blood supply (1) 1
breast neoplasms - diagnostic imaging (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - epidemiology (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - pathology (1) 1
ca 15-3 antigen (1) 1
cancer patients (1) 1
cancer therapies (1) 1
candidate tumor-suppressor (1) 1
carcinoma (1) 1
carcinoma, ovarian epithelial (1) 1
care and treatment (1) 1
caspase (1) 1
cell (1) 1
cell hypoxia - drug effects (1) 1
cell line, tumor (1) 1
cells (1) 1
cetuximab (1) 1
cgh (1) 1
chromosome 6q (1) 1
chromosome deletion (1) 1
chromosomes, human, pair 6 - genetics (1) 1
cisplatin (1) 1
cisplatin-sensitivity (1) 1
clinical trials (1) 1
clonal deletion (1) 1
colonic neoplasms - drug therapy (1) 1
colonic neoplasms - etiology (1) 1
colonic neoplasms - genetics (1) 1
colorectal cancer (1) 1
comparative analysis (1) 1
comparative genomic hybridization (1) 1
computerized analysis (1) 1
copy number (1) 1
cystadenocarcinoma, serous - genetics (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Breast Cancer Research, ISSN 1465-5411, 07/2015, Volume 17, Issue 1, p. 93
Journal Article
Molecular Oncology, ISSN 1574-7891, 05/2016, Volume 10, Issue 5, pp. 704 - 718
Rationalization of antiangiogenics requires biomarkers. Vascular re-normalization is one widely accepted mechanism of action for this drug class. The... 
18F-misonidazole-PET | Biomarker | Vascular normalization | Breast cancer | Antiangiogenics | Pancreatic cancer | 18F‐misonidazole‐PET | F-misonidazole-PET | Edema | Gemcitabine | Clinical trials | Caspase | FDA approval | Equilibrium | Dextran | Angiogenesis | Hypotheses | Chemotherapy | Misonidazole | Extravasation | Xenografts | Hypoxia | Pancreas | Cancer | Tumors
Journal Article
Molecular Oncology, ISSN 1574-7891, 02/2015, Volume 9, Issue 2, pp. 422 - 436
Journal Article
Future Oncology, ISSN 1479-6694, 03/2018, Volume 14, Issue 7s, pp. 29 - 36
Hepatic impairment in breast cancer arises from metastatic spread of tumor cells to the liver and signals a poor prognosis. Systemic therapy is the mainstay of... 
hepatic metastases | eribulin | metastatic breast cancer | LIVER METASTASES | MESYLATE | MANAGEMENT | THERAPY | ONCOLOGY | ANTHRACYCLINE | GUIDELINES
Journal Article
Molecular Oncology, ISSN 1574-7891, 05/2016, Volume 10, Issue 5, p. 704
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.molonc.2015.12.011... 
Antimitotic agents | Dextran | Pets | Analysis | Pancreatic cancer | Antineoplastic agents
Journal Article
Journal Article
Journal Article
Journal of Gynecologic Oncology, ISSN 2005-0380, 01/2016, Volume 27, Issue 1, pp. e7 - e7
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.